FundCanna $60 million credit facility brings institutional capital into cannabis lending

FundCanna has secured a senior credit facility of up to $60 million, giving the cannabis finance platform more capital to fund operators across one of the most underserved credit markets in the country. The deal is notable because it brings institutional capital into unsecured cannabis lending, a segment many traditional lenders and banks have historically avoided.

FundCanna has secured a senior credit facility of up to $60 million, marking a significant financing milestone for a cannabis industry that still struggles to access traditional credit.

The San Diego-based cannabis funding platform announced that the facility is backed by a global institutional investment firm with approximately $40 billion in assets under management. The credit line provides $35 million at closing, with additional capital available as FundCanna continues to scale its portfolio. Combined with new and existing investor participation, FundCanna says its broader capital base now totals approximately $75 million.

For the cannabis industry, the headline is not just the size of the facility. It is the type of capital entering the market.

Why This Deal Matters

Cannabis businesses have long operated in a financial gray area. Even in states where cannabis is legal, federal restrictions have made many banks cautious about serving operators, especially when it comes to lending. Banks must still consider both state and federal law, which creates risk when working with state-legal cannabis-related businesses.

That has left many cannabis operators relying on private lenders, equity investors, sale-leaseback structures, real estate-backed loans, or expensive short-term financing. FundCanna’s announcement stands out because the company is focused on non-real estate capital and unsecured lending to operating businesses, including retailers, manufacturers, distributors, multi-state operators, and other participants in the cannabis supply chain.

“This is institutional capital entering a part of the market it has historically avoided,” FundCanna founder and CEO Adam Stettner said in the announcement. He described the company’s platform as one built to serve both established operators and the broader supply chain, where access to reliable funding has remained inconsistent.

FundCanna’s Growth So Far

FundCanna says it has deployed more than $250 million in capital since inception after initially raising approximately $25 million from private investors. That reflects roughly 10 times capital deployment relative to its initial raise.

The company has also originated more than 5,000 transactions and says it will soon exceed a $100 million annualized run rate. Based on its historical capital velocity, FundCanna expects the new capital structure to support more than $500 million in cumulative funding across the cannabis industry over the next several years.

Those numbers are important because cannabis lending is not a market where capital alone solves the problem. Lenders need underwriting discipline, specialized knowledge, and a strong understanding of the legal, operational, and cash flow challenges that cannabis businesses face.

Stettner said cannabis has proven to be “a stronger credit market than many expect,” but also one of the most difficult markets to underwrite properly because the data is fragmented, laws vary by state, and many lenders underestimate how different the industry can be.

A Bigger Signal for Cannabis Finance

The timing of this facility is also important.

The cannabis industry has been waiting for years for more clarity around banking access. The SAFER Banking Act has been discussed as a way to give financial institutions more protection when serving state-legal cannabis businesses, but it has faced repeated delays and still would not fully resolve cannabis’s broader federal legal uncertainty. Reuters has reported that even banking reform would not solve all access-to-capital issues for cannabis businesses, particularly for smaller operators and companies seeking broader credit-market support.

More recent reporting has also shown that even regulatory progress may not immediately open the doors of major banks. Large financial institutions remain cautious because cannabis still carries federal legal and compliance risk.

That is where specialized lenders like FundCanna can play a major role. Instead of waiting for traditional banks to become comfortable with the industry, FundCanna is building financing products around the realities of cannabis operations.

According to the company’s website, FundCanna offers fast, flexible cannabis financing, including working capital, vendor, equipment, dispensary, and inventory financing, with approvals possible in as little as 24 hours.

The ReadyPaid Platform and the Receivables Problem

One of the more interesting parts of FundCanna’s announcement is its ReadyPaid™ Buy Now, Pay Later platform.

The company says ReadyPaid is designed to address nearly $4 billion in delinquent accounts receivable across the cannabis supply chain. In simple terms, many cannabis sellers are extending terms to buyers, but then waiting too long to get paid. That creates a liquidity problem that can ripple through the entire supply chain.

ReadyPaid is meant to help sellers get paid upfront while giving buyers more flexible payment terms. FundCanna says the platform can produce underwriting decisions in minutes and has processed several million dollars in transactions with no reported delinquencies to date.

This is where the story becomes bigger than just another credit facility. If FundCanna can use institutional capital to improve payment flow between cannabis brands, distributors, retailers, and other supply-chain participants, it could help reduce one of the industry’s most persistent working capital bottlenecks.

For larger multi-state operators and established brands, that kind of liquidity can support wholesale growth without forcing the seller to act like the bank for every customer.

The Bottom Line

FundCanna’s $60 million senior credit facility is a sign that cannabis lending is slowly becoming more institutional, even while the industry continues to face major banking limitations.

If FundCanna can continue proving the credit performance of this market, it may help shift the perception of cannabis finance from a fringe lending category to a serious specialty credit vertical.

For an industry that has spent years operating with limited access to reliable financing, that shift could be meaningful.